Plant Health Care plc (LON:PHC)‘s stock had its “buy” rating reaffirmed by research analysts at Liberum Capital in a report released on Sunday, StockTargetPrices.com reports. They currently have a GBX 120 ($1.71) price target on the stock. Liberum Capital’s price objective would suggest a potential upside of 60.00% from the company’s current price.

Plant Health Care plc (LON:PHC) opened at 75.00 on Friday. The stock’s 50 day moving average price is GBX 82.14 and its 200 day moving average price is GBX 90.37. The firm’s market cap is GBX 53.78 million. Plant Health Care plc has a 1-year low of GBX 70.00 and a 1-year high of GBX 129.00.

Plant healthcare plc is an agricultural bio-technology company. The Company provides biological products for the agricultural markets. The Company’s bio-stimulants are products, which mobilize plants to increase yields and to defend themselves against attack by pests or from the debilitating effects of drought. The Company’s brands include Myconate, Harpin, ProAct, N-Hibit and Innatus. The Company’s products consist of three segments: Europe, Mexico and the United States. The Company operates its business in two areas: discovery and commercial products. The Company’s discovery area is focused on the discovery and evaluation of bio-stimulants, which it intends to license to companies for further development, registration and sale. The Company’s commercial products area is focused on the commercialization and sale of bio-stimulant and related products.

Stock Target Prices

Receive News & Ratings for Plant Health Care plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plant Health Care plc and related companies with MarketBeat.com's FREE daily email newsletter.